CLINICAL_TRIALS
trial_result
· 2020-03-11
Clinical Trial Update: Apixaban in Patients With Sickle Cell Disease [Phase 3]
Summary
Phase 3 trial update for apixaban in sickle cell disease was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nirmish Shah | Conditions: Vaso-occlusive Crisis, Reduction in Hospitalizations | Phase 3 | Status: TERMINATED | Results posted: 2020-03-11